申请人:BOEHRINGER INGELHEIM INT
公开号:WO2010012745A2
公开(公告)日:2010-02-04
The present invention encompasses compounds of general formula (1); wherein R1, R2 and X are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.